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Complex oligosaccharides from human milk (HMO) possess an antimicrobial activity
and can promote the growth of bifidobacteria such as Bifidobacterium bifidum and
Bifidobacterium longum subsp. infantis. In addition, fermentation of carbohydrates by
bifidobacteria can result in the production of metabolites presenting an antivirulence
effect on several pathogenic bacteria. Whey is rich in complex bovine milk
oligosaccharides (BMO) structurally similar to HMO and B. crudilactis, a species of bovine
origin, is able to metabolize some of those complex carbohydrates. This study focused
on the ability of B. bifidum and B. crudilactis to grow in a culture medium supplemented
in 3′-sialyllactose (3′SL) as the main source of carbon, a major BMO encountered in
cow milk. Next, the effects of cell-free spent media (CFSM) were tested against virulence
expression of Escherichia coli O157:H7 and Salmonella enterica serovar Typhimurium.
Both strains were able to grow in presence of 3′SL, but B. crudilactis showed the best
growth (7.92 ± 0.3 log cfu/ml) compared to B. bifidum (6.84 ± 0.9 log cfu/ml). Then,
CFSM were tested for their effects on virulence gene expression by ler and hilA promoter
activity of luminescent mutants of E. coli and S. Typhimurium, respectively, and on wild
type strains of E. coli O157:H7 and S. Typhimurium using RT-qPCR. All CFSM resulted
in significant under expression of the ler and hilA genes for the luminescent mutants
and ler (ratios of −15.4 and −8.1 respectively) and qseA (ratios of −2.1 and −3.1) for
the wild type strain of E. coli O157:H7. The 3′SL, a major BMO, combined with some
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bifidobacteria strains of bovine or human origin could therefore be an interesting synbiotic
to maintain or restore the intestinal health of young children. These effects observed
in vitro will be further investigated regarding the overall phenotype of pathogenic agents
and the exact nature of the active molecules.
Keywords: Bifidobacterium bifidum, Bifidobacterium crudilactis, bovine milk oligosaccharide, Escherichia coli
enterohemorragic O157:H7, Salmonella enterica serovar Typhimurium, virulence expression, 3′-sialyllactose,
whey
INTRODUCTION
Due to the influence on the microbiota of carbohydrate
source present in food, breast-fed children are generally in
better health than children fed with formula (Arrieta et al.,
2014; Smilowitz et al., 2014; Scott et al., 2015). Human
milk oligosaccharides (HMO) are complex oligosaccharides
found in human milk. Their concentration can reach 15 g/l
and more than 500 structures have been identified (Pacheco
et al., 2015). These HMO, produced in mammary glands,
cannot be metabolized either by the host or most bacteria,
while bifidobacteria species have enzymatic activity able to
degrade specific α- and β-bonds (Garrido et al., 2013). These
bacteria such as Bifidobacterium bifidum subsp. infantis or
Bifidobacterium bifidum are mainly found in the feces of
breast-fed children. Indeed, the fecal microbiota of breast-
fed child contain more than 75% bifidobacteria (Di Gioia
et al., 2014). In addition to facilitating the growth of beneficial
bacteria such as bifidobacteria, HMO can bind with pathogenic
virus or bacteria, limiting adhesion to intestinal epithelium
and therefore decreasing pathogens colonization by promoting
natural excretion (Smilowitz et al., 2014). Also, other metabolites
produced by lactic acid bacteria and bifidobacteria are able to
inhibit virulence gene expression of Escherichia coli O157:H7
(Medellin-Pena and Griffiths, 2009; Zeinhom et al., 2012),
Salmonella enterica serovar Typhimurium SA 941256 (Medellin-
Pena et al., 2007; Bayoumi and Griffiths, 2012; S. Typhimurium)
and Campylobacter jejuni (Mundi et al., 2013).
Five monosaccharides can be found in different HMO
structures: glucose (Glc), galactose (Gal), N-acetylglucosamine
(GlcNAc), fucose (Fuc), and sialic acid, also called N-
acetylneuraminic (NeuAc). High quantities of lacto-N-biose type
I (LNB: Galβ1-3GlcNAc) and fucosylated HMO are an important
characteristic of human milk (Chichlowski et al., 2011; Garrido
et al., 2013; Dotz et al., 2014; Smilowitz et al., 2014). B. infantis is
able to fully degrade HMO intracellularly, contrary to B. longum,
B. breve, and B. bifidum (Sela and Mills, 2010; Underwood
et al., 2015). It possesses genes encoding specific transporters and
four enzymes necessary for HMO degradation (α-fucosidase, α-
sialidase, β-galactosidase, and β-N-hexosaminidase) (Sela et al.,
Abbreviations: 3′SL, 3′-sialyllactose; AE, attaching and effacing; BHI, brain
heart infusion; BMO, bovine milk oligosaccharide; CFSM, cell-free spent
medium; EHEC, enterohaemorragic Escherichia coli; FOS, fructo-oligosaccharide;
Fuc, fucose; Gal, galactose; Glc, glucose; GlcNAc, N-acetylglucosamine;
GOS, galacto-oligosaccharide; HMO, human milk oligosaccharide; LacNac,
N-acetyllactosamine; LB, Luria Bertani; LNB, lacto-N-biose; LNnT, lacto-N-
neotetraose; LNT, lacto-N-tetraose; MRS, De Man, Rogosa and Sharpe medium;
NeuAc, N-acetylneuraminic acid or sialic acid; NeuGc, N-glycolylneuraminic
acid; OD, optical density; T3SS, type III secretion system.
2008; Sela, 2011; Smilowitz et al., 2014). HMO degradation
by B. bifidum occurs outside the cells. Indeed, B. bifidum
possesses a lacto-N-biosidase, which cleaves LNB from HMO.
LNB is internalized using a specific transport system and is then
degraded using LNB-phosphorylase (Sela, 2011; Smilowitz et al.,
2014). Therefore, B. infantis and B. bifidum, despite their different
gene clusters, both grow very well in the presence of HMO as sole
source of carbon (Asakuma et al., 2011; Barile and Rastall, 2013).
Common oligosaccharides used in infant formula are galacto-
oligosaccharides (GOS) and fructo-oligosaccharides (FOS),
including inulin. GOS are composed of Glc and Gal, while
FOS are composed of fructose and Glc. Their structures are
very simple and linear. They are also bifidogenic, but because
of their simple structure, they can also be consumed by other
members of the intestinal microbiota such as Bacteroides spp.
or Clostridium spp. (Chichlowski et al., 2011; Scholtens, 2014).
This is probably why the fecal microbiota of formula-fed children
contains only 30% bifidobacteria (Di Gioia et al., 2014) and the
species that are present are different from those observed in the
feces of breast-fed children. The predominant bifidobacteria in
formula-fed children are those encountered in adult feces, such
as Bifidobacterium longum subsp. longum and Bifidobacterium
adolescentis, which present a less diverse enzymatic arsenal (De
Vuyst et al., 2013).
Bovine milk oligosaccharides (BMO) can have similar
composition and branching as HMO, so they could share some
common properties. In addition, B. infantis or B. bifidum can
grow in the presence of these carbohydrates (Sela, 2011; Milani
et al., 2014). More than 60 BMO have been identified so far
(Pacheco et al., 2015) and whey, a by-product of the dairy
industry, is an important low cost source of BMO (Barile et al.,
2009; Zivkovic and Barile, 2011). Furthermore, Lactobacillus
acidophilus La-5 grown in medium supplemented with dairy
ingredients such as whey, presented a protective effect in
EHEC-infected mice (Zeinhom et al., 2012). However, BMO
concentration in bovine milk is lower than HMO concentration
in human milk (Barile et al., 2009; Tao et al., 2009; Kelly et al.,
2013). Also, fucosylation occurs at very low frequency compared
to sialylation, which is contrary to human milk (Tao et al.,
2008). Even if the degree of polymerization in BMO is lower
than in HMO, they are also protected by α- and β-bonds which
are less accessible to other bacteria (Chichlowski et al., 2011).
One of the most important BMO found in cow milk is 3′-
sialyllactose (3′SL: NeuAcα2-3Galβ1-4Glc) and its concentration
in colostrum can reach 0.85 mg/ml (Nakamura et al., 2003;
Urashima et al., 2013). The majority of bifidobacteria grows
only in anaerobic conditions, an environment very difficult to
reproduce on an industrial scale. In addition, they have to survive
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the acidity of the stomach, bile salts and pancreatic enzymatic
activity of the digestive tract in order to reach the colon where
they will consume oligosaccharides. Bifidobacterium crudilactis
FR/62/B/3, a species isolated from raw cow’s milk cheese, is
oxygen tolerant (Daube et al., 2006; Delcenserie et al., 2013). The
genome encodes enzymes degrading BMO (Delcenserie et al.,
2007;Milani et al., 2014). These strains from bovinemilk could be
an interesting source of probiotics for formula supplementation
(Delcenserie et al., 2013).
The type III secretion system (T3SS) has a major role in
virulence expression of S. Typhimurium and E. coli O157:H7
by injecting effector proteins in intestinal cells and forming
attaching and effacing (AE) lesions on host enterocytes (Bayoumi
and Griffiths, 2012). The proteins produced by S. Typhimurium
are controlled and activated by hilA and sopD genes and the
ssrB2 gene is a major regulator of the T3SS (Guri et al., 2016).
Regarding E. coli O157:H7, AE lesions are controlled by a
pathogenicity island named locus of enterocyte effacement (LEE)
through ler gene, which is regulated by qseA gene also implicated
in quorum sensing (Medellin-Pena et al., 2007). The gene luxS,
major regulator of quorum sensing and influencing the qseA and
ler genes, is also involved in expression of genes encoding flagella
and biofilm formation (fliC) or synthesis of shiga-toxin (stxB2)
(Kaper et al., 2004; Wood et al., 2006).
The aims of this work were therefore to study the growth
potential of B. crudilactis FR/62/B/3 compared to B. bifidum
BBA1 in culture media supplemented with whey or 3′SL and
to evaluate the effects of CFSM on virulence expression of
Escherichia coli O157:H7 and Salmonella Typhimurium. Because
of its bovine origin, the hypothesis is that B. crudilactis FR/62/B/3
can metabolize components present in whey, especially BMO,
as explained previously. B. bifidum BBA1, a strain isolated from
breastfed children feces, was chosen to provide a comparison
with a strain of human origin as this strain should be able
to use BMO or 3′SL as a source of carbon, due to their
similarity with HMO (Zivkovic and Barile, 2011). Tanimomo
et al. (2016) developed a culture medium answering to the
specificities of B. crudilactis FR/62/B/3. This formula, more
suited to bifidobacteria from bovine origin, was used in this
study as an optimized medium in which different sources of
carbohydrates have been tested. The effects of CFSM obtained
from theses cultures on intestinal pathogens virulence were
firstly investigated using rapid-testing on a luminescent reporter
mutants. Next, virulence gene expression was more deeply
investigated on several virulence genes using RT-qPCR on wild
pathogenic strains. A special attention was given to the controls
(unfermented media). Indeed, some nutrients have previously
been shown to have a repressive effect on virulence gene
expression of E. coli O157:H7 (Delcenserie et al., 2012) and
therefore, it was important to exclude that potential effect from
the observed results with the fermented media.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
B. bifidum BBA1 was isolated from feces from a breast-fed
child (CHU - Hôpital des Bruyères, Liège, Belgium) and B.
crudilactis FR/62/B/3 from Saint-Marcellin, a raw cow milk
cheese from Vercors (France). Both strains were stored at
−80◦C and grown on De Man, Rogosa, and Sharpe (MRS)
medium (Oxoid, Hampshire, UK) supplemented with cysteine-
HCl (0.5 g/l) and mupirocin (0.08 g/l) at 37◦C for 48 h in an
anaerobic workstation (Led Techno, Heusden-Zolder, Belgium)
containing 10% H2, 10% CO2, and 80% N2. Several successive
cultures, in the same conditions as described previously, have
been carried out in MRS broth, prior to use. Pathogenic
enterohaemorrhagic E. coli (EHEC) strain O157:H7 ATCC 43890
(stx2+) and S. enterica serovar Typhimurium strain ATCC 14028
were stored at −80◦C and grown in Luria Bertani (LB) media
(Sigma-Aldrich, Diegem, Belgium). Two reporter mutants, E. coli
O157:H7 ATCC 43888 (stx−, LEE:lux) containing plasmid LEE1-
luxCDABE and resistant to ampicillin (Ampr) and kanamycin
(Kanr) and S. Typhimurium SA 941 256 containing plasmid
pSB377 (hilA::luxCDABE; Ampr) were designed by Medellin-
Pena et al. (2007) and Bayoumi and Griffiths (2010), respectively.
Both strains were from the Canadian Research Institute for Food
Safety Collection and were grown under aerobic conditions at
37◦C in brain heart infusion (BHI) broth (Bio-Rad, Marnes-
la-coquette, France) supplemented with ampicillin (50 mg/l). A
medium optimized for B. crudilactis FR/62/B/3, called MRS2
(Tanimomo et al., 2016) was considered as the reference
medium for this study (Table 1) and was modified by removing
or replacing glucose: MRS2 without any glucose (MRS2 G)
(control), MRS2 with a mix of glucose and whey (MRS2-
Wh), and MRS2 with 3′SL (MRS2-3′SL) as the main source of
carbohydrate (Table 1). Whey was collected at the beginning
of a curdling process of a Belgian cheese factory (Liège area,
Belgium) and frozen at −20◦C before further use. The quantity
of lactose inMRS2-Whmediumwas estimated to 25 g/l, based on
lactose concentration of sweet whey (50 g/l of lactose; Food and
Agriculture Organization/Organisation Mondiale de la Santé,
1998). However, mature bovinemilk contains only traces of BMO
(Kelly et al., 2013). The 3′SL, added to MRS2-3′SL, was provided
by Carbosynth laboratory (Berkshire, UK). The concentration
of 0.85 g/l was chosen to be close to natural concentrations
TABLE 1 | Composition of modified MRS2 media.
MRS2 G MRS2 MRS2-Wh MRS2-3′SL
Yeast extract (g/l) 15.5 15.5 15.5 15.5
Peptone of casein (g/l) 15.5 15.5 15.5 15.5
K2HPO4 (g/l) 0.9 0.9 0.9 0.9
KH2PO4 (g/l) 0.9 0.9 0.9 0.9
NaCl (g/l) 0.009 0.009 0.009 0.009
MnSO4.H2O (g/l) 0.17 0.17 0.17 0.17
MgSO4.7H2O (g/l) 0.007 0.007 0.007 0.007
FeSO4.7H2O (g/) 0.009 0.009 0.009 0.009
Tween 80 (ml/l) 0.9 0.9 0.9 0.9
Cysteine (g/l) 0.4 0.4 0.4 0.4
Glucose (g/l) – 20 10 –
Whey (ml/l) – – 500 –
3′-sialyllactose (g/l) – – – 0.85
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found in colostrum (Nakamura et al., 2003). B. bifidum BBA1
and B. crudilactis FR/62/B/3 were grown in three independent
experiments under anaerobic conditions at 37◦C for 48 h to reach
7 log/ml. Next, the cultures were used to inoculate fresh media
to reach 5 log/ml of bifidobacteria (1% v/v). The concentration
of 5 log/ml was confirmed by plating several dilutions of
bifidobacteria at day 0 post inoculation. Bacterial growth was
determined by viable counts after 48 h incubation. Cell free spent
media (CFSM) were obtained after two centrifugation steps at
5000× (Eppendorf Centrifuge 5804, Hamburg, Germany) for 10
min. Supernatants were then sterilized by filtration (Minisart R©
0.45µmand 0.2µm, Sartorius, Vilvoorde, Belgium). Next, CFSM
were freeze-dried (Virtis Benchtop 3.3 EL, SP Scientific, Suffolk,
United-Kingdom) and rehydrated with sterile distilled water to
obtain a 10x concentration. The same treatment was applied to
non-fermented culture media (controls). The pH of rehydrated
CFSM was adjusted to 7 using 1M NaOH.
Measurement of LEE and hilA Promoter
Activity
Both E. coli reporter strains were grown overnight in BHI
broth supplemented with ampicillin (BHI-Amp). Each
overnight culture was diluted 1:100 with fresh BHI-Amp
broth supplemented (test samples) or not (control samples) with
10% concentrated CFSM obtained from fermented MRS2-3′SL.
Two hundred microliters of each sample were distributed into
triplicate wells of a sterile, opaque 96-well microliter plate
(Corning 3610, Fisher Scientific, Ottawa, Ontario, Canada) and
incubated at 30◦C. Luminescence was measured every hour for
24 h, with a Victor multilabel counter (Wallac, PerkinElmer Life
Sciences Canada, Woodbridge, Ontario, Canada). Luminescence
was expressed in counts per second. Optical density (OD) was
determined using a Genesys 20 spectrophotometer (Thermo
scientific, Erembodegen, Belgium) adjusted to 600 nm.
Contact between Concentrated CFSM
and Wild Type Pathogenic Strains
E. coli O157:H7 ATCC 43890 was grown in LB agar and a single
colony was taken from the plate and incubated overnight in LB
broth at 37◦C with aeration. The same procedure was applied for
S. Typhimurium ATCC 14028 using BHI medium. The cultures
were homogenized and 50 µl were diluted in 4.5ml of LB broth
for E. coli and BHI broth for S. Typhimurium. Then, 450 µl of
each concentrated CFSM was added to the bacterial suspensions.
Triplicate cultures were incubated at 37◦C for 4 h on a shaker at
150 rpm. Bacterial growth was determined by OD measurement
at 600 nm. E. coli O157:H7 and S. Typhimurium were grown in
LB and BHI broth alone, respectively, as controls.
Gene Expression Analysis by RT-qPCR
The method was adapted with some modifications from Tellez
et al. (2012), Mith et al. (2014) and Guri et al. (2016). After
4 h of incubation (Delcenserie et al., 2012), cells were collected
by centrifugation at 5000 × g for 10 min at room temperature
(Eppendorf Centrifuge 5804, Hamburg, Germany). The pellet
was suspended in 100 µl TE buffer (10 mM Tris and 1 mM
EDTA) containing 1% lysozyme (Roche, Mannheim, Germany).
Samples were stored at −20◦C overnight. On the next day,
RNA was extracted using the RNeasy R© Mini Kit (Qiagen,
Antwerp, Belgium). DNA contamination was eliminated from
each sample using the DNase I Recombinant RNase-free Kit
(Roche Diagnostics GmbH, Mannheim, Germany). To inactivate
the DNase, samples were heated at 75◦C for 10 min. The
quantity of RNA was determined by measuring the absorbance
at 260 nm using a Nanodrop 2000 Spectrophotometer (Thermo
Scientific, USA). The purity and quality of RNA were verified
by measuring the ratio of absorbance (260 nm/280 nm) and by
using agarose gel electrophoresis (Eurogentec, Seraing, Belgium).
The concentration of RNA used for reverse transcription
was normalized to 100 ng/µl for E. coli and to 50 ng/µl for
S. Typhimurium. Next, the RNA was subjected to reverse
transcription polymerase chain reaction (RT-PCR) using a high-
capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Ghent, Belgium). Briefly, 1 µg of RNA was reverse transcribed
with 0.8 µl of desoxyribonucleoside triphosphate (dNTP;
100mM), 1 µl of Multiscribe R© Reverse Transcriptase (50U/µl),
2 µl of 10X RT Random Primers and 2 µl of 10X RT Buffer in an
adjusted total volume of 20 µl. For each sample, a no-RT control
was included to confirm the absence of DNA contamination.
Synthesis of cDNA was performed in a Mastercycler Gradient
Thermocycler (Flexigene, Cambridge, UK) under the following
conditions: 25◦C for 10 min, 37◦C for 120 min, 85◦C for 5 min
and a cooling step at 4◦C. Then, cDNA was stored at−20◦C.
To study the effects of bioactive molecules present in culture
supernatant on gene expression of E. coli O157:H7 ATCC
43890, the expression of genes ler (involved in attaching effacing
lesions), fliC (involved in mobility), stxB2 (encoding subunit
B of Shiga-toxin 2), luxS (major regulator of quorum sensing
and producing AI-2), and qseA (involved in quorum sensing
and regulator of LEE expression) was determined using qPCR.
The same method was used to study effects on S. Typhimurium
virulence gene expression of hilA (invasion protein regulator),
ssrB2 (Type III secretion system regulator), and sopD (secreted
effector protein). Quantitative PCR amplification was conducted
using the GoTaq R© qPCR Master Mix (Promega, Leiden,
Netherlands) and using the ABI 7300 Real Time PCR System
(Applied Biosystems, Singapore) for E. coli or the Light
Cycler 480 (Roche Diagnostics, Mannheim, Germany) for S.
Typhimurium. The primers were synthesized by Eurogentec
(Liège, Belgium) and have been used in previous studies
(Table 2). The RT-qPCR was performed in a total volume of 20
µl, containing 10µl of GoTaq R©Master Mix, 5.75µl of molecular
grade water, 1 µl of forward primer (10 µM), 1 µl of reverse
primer (10 µM), 0.25 µl of carboxy-X-rhodamine (30 µM), and
2 µl of diluted cDNA. The qPCR conditions for E. coli were:
initial denaturation at 95◦C for 3 min; denaturation, annealing
and elongation repeated 45 times: 95◦C for 15 s, 58◦C for 30 s and
72◦C for 45 s; melting curve program: 60–95◦C with a heating
rate of 0.1◦C/s. The qPCR conditions for S. Typhimurium were:
denaturation at 95◦C for 10 min; 40 cycles of amplification and
quantification: 95◦C for 30 s, 56◦C for 30 s and 72◦C for 30 s;
melting curve program: 60–95◦C with a heating rate of 0.1◦C s.
The annealing temperature, optimized at 56◦C, was determined
experimentally. Each specific amplicon was validated for the
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presence of a single melting temperature peak and a single
band of expected size on a 2% agarose gel after electrophoresis.
Cycle threshold (Ct) values were determined using the ABI 7300
System SDS Software for E. coli and the Light Cycler Software 480
version 1.5 for S. Typhimurium. Four housekeeping genes were
tested for E. coli: gnd (6-phosphogluconate deshydrogenase),
gst (glutathione S-transferase), 16S gene (ribosomal RNA) and
recA (recombinase A). Three housekeeping genes were tested
for S. Typhimurium: gmk (guanylate kinase), rpoD (sigma
factor) and 16S gene (ribosomal RNA gene). Because recA
and gmk were the most stable under different treatments,
they were selected for normalizing transcript expression
levels. The experiments were replicated three independent
times. To determine relative changes in gene expression,
the formula described by Pfaﬄ (Pfaﬄ, 2001) was used: ratio =
(Etarget)1Ct target(control-sample)/(Ereference)
1Ct reference(control-sample),
TABLE 2 | Primers of virulence genes used for qPCR (F: forward;
R: reverse).
Primer Sequence of PCR primers (5′-3′)a References
E. coli Housekeeping and Virulence Genes
gnd
F: 5′-GGTAATACCTTCTTCCAGGACACC-3′
Rashid et al., 2006
R: 5′-TAGTGCGCCCTCCTCACC-3′
gst
F: 5′-CTTTGCCGTTAACCCTAAGGG-3′
Pfaffl, 2001
R: 5′-GCTGCAATGTGCTCTAACCC-3′
recA
F: 5′-CAATATTCCCCACTGCTGCC-3′
Takle et al., 2007
R: 5′-CACCTAGGCGACGATCCCT-3′
16S
F: 5′-GGTGAGCTGGTTGATCTGGG-3′
Takle et al., 2007
R: 5′-GCATTCGCTTTACCCTGACC-3′
ler
F: 5′-TTTCTTCTTCAGTGTCCTTCA-3′ Medellin-Pena
et al., 2007R: 5′-TGCGGAGATTATTTATTATGA-3′
fliC
F: 5′-TACCATCGCAAAAGCAACTCC-3′ Medellin-Pena
et al., 2007R: 5′-GTCGGCAACGTTAGTGATACC-3′
luxS
F: 5′-GATCATACCCGGATGGAAG-3′ Medellin-Pena
et al., 2007R: 5′-AGAATGCTACGCGCAATATC-3′
stxB2
F: 5′-AGATGTTTATGGCGGTTTTA-3′ Medellin-Pena
et al., 2007R: 5′-TTAAACTGCACTTCAGCAAA-3′
qseA
F: 5′-CGCGGATCCCGTTGGCACAGGTTTGTACA-3′ Medellin-Pena
et al., 2007R: 5′-CGCGGATCCCGTTGGCACAGGTTTGTACA-3′
S. Typhimurium Housekeeping and Virulence Genes
gmk
F: 5′-TTGGCAGGGAGGCGTTT-3′
Rashid et al., 2006
R: 5′-GCGCGAAGTGCCGTAGTAAT-3′
rpoD
F: 5′-ACATGGGTATTCAGGTAATGGAAGA-3′ Botteldoorn et al.,
2006R: 5′-CGGTGGGTATTCAGGTAATGGAAGA-3′
16S
F: 5′-AGGCCTTCGGGTTGTAAAGT-3′
Xu et al., 2010
R: 5′-GTTAGCCGGTGCTTCTTCTG-3′
hilA
F: 5′-TGTCGGAAGATAAAGAGCAT-3′
Guri et al., 2016
R: 5′-AAGGAAGTATCGCCAATGTA-3′
sopD
F: 5′-ATTAATGCCGGTAACTTTGA-3′
Guri et al., 2016
R: 5′-CTCTGAAAACGGTGAATAGC-3′
ssrB2
F: 5′-TGGTTTACACAGCATACCAA-3′
Guri et al., 2016
R: 5′-GGTCAATGTAACGCTTGTTT-3′
where E is the efficiency of the qPCR, calculated according to the
equation: E= 10(−1/slope).
Statistical Analysis
The data are means ± standard error of three replicates. A
Student’s t-test was used to assess the statistical significance of
the differences between test and control groups, where p ≤ 0.05
was considered as significant.
RESULTS
Growth of Bifidobacterium bifidum and
Bifidobacterium crudilactis
B. crudilactis FR/62/B/3 showed increase in viable counts in
MRS2, MRS2-Wh and MRS2-3′SL compared to MRS2 G, but the
highest counts were observed onMRS2-Wh (8.9± 0.6 log cfu/ml,
Table 3). The same trend was observed for B. bifidum BBA1
with slightly lower counts (Table 3) compared to B. crudilactis
FR/62/B/3. The highest counts were also observed for MRS2-Wh
(8.1± 0.3 log cfu/ml).
Activity of CFSM from MRS2-3′SL
Fermented by Bifidobacteria on
Bioluminescent Reporter Gene Expression
Luminescence expression of the plasmids LEE::luxCDABE and
hilA:luxCDABE reached its maximum at 4 h for the E. coli
mutant and at 13 h for the S. Typhimurium mutant, respectively.
In the presence of supernatants from fermented MRS2-3′SL
medium, bioluminescence induction decreased for both mutants
(Figures 1, 2) showing a decrease in promoter expression of
ler and hilA. These results, statistically significant for both
strains, were more pronounced for hilA gene expression of
S. Typhimurium (Figure 2).
Effect of CFSM on E. coli O157:H7
Virulence Gene Expression
After incubation of 4 h, the different CFSM had no negative
impact on growth. The average OD of E. coli O157:H7 at
600 nm after 4 h exposure was around 1.286 ± 0.119. From
every tested housekeeping gene, recA was the most stable and
was chosen to normalize the results according to the efficiency
of each pair of primers (virulence genes ler, fliC, stxB2, luxS,
and qseA) monitored using qPCR (Pfaﬄ, 2001; Tellez et al.,
2012) (Table 4). The fermented MRS2 G, MRS2, and MRS2-
Wh media did not show significant impact on gene expression
TABLE 3 | Counts of B. bifidum and B. crudilactis after 48 h of incubation
in MRS2 G, MRS2, MRS2-Wh, and MRS2-3′SL media.
Final concentrations after 48h incubation (log cfu/ml)
B. bifidum B. crudilactis
MRS2 G 6.9 ± 0.3 5.5 ± 0.5
MRS2 7.3 ± 0.8 7.8 ± 1.4
MRS2-Wh 8.1 ± 0.3 8.9 ± 0.6
MRS2-3′SL 6.8 ± 0.9 7.9 ± 0.3
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FIGURE 1 | Effect of CFSM from MRS2-3′SL medium fermented with B. bifidum and B. crudilactis on E. coli O157:H7 (stx−, LEE1:lux) ATCC 43888
expression. The E. coli control is E. coli grown on BHI only. The MRS2-3′SL control is E. coli grown on BHI and CFSM from MRS2-3′SL medium unfermented. Data
are the means ± the standard deviations derived from triplicate and expressed as relative light units (RLU) defined as counts per seconds, adjusted to OD600
(RLU/OD600) and where OD is fixed at 0.806 and was taken after 4 h of incubation. LUM: luminescence; OD: optical density. ***P ≤ 0.005.
FIGURE 2 | Effect of CFSM from MRS2-3′SL medium fermented with B. bifidum and B. crudilactis on S. Typhimurium (hilA::lux) SA 941256 expression.
The Salmonella control is Salmonella grown on BHI only. The MRS2-3′SL control is S. Typhimurium grown on BHI and CFSM from MRS2-3′SL medium unfermented.
Data are the means ± the standard deviations derived from triplicate and expressed as relative light units (RLU) defined as counts per seconds, adjusted to OD600
(RLU/OD600) and where OD is fixed at 0.909 and was taken after 13 h of incubation. LUM: luminescence; OD: optical density. ***P ≤ 0.005.
(Figures 3A–C) compared to non-fermented control media,
meaning that CFSM had no effects. However, significant down-
regulation of virulence genes of E. coli O157:H7 was observed
in the presence of fermented MRS2-3′SL medium (Figure 3D).
The medium fermented by B. bifidum BBA1 and B. crudilactis
FR/62/B/3 induced a down-regulation of the E. coli ler gene
(ratios of −15.4; P ≤ 0.01 and −8.1; P ≤ 0.05, respectively).
A down-regulation of the qseA gene was also observed (ratios
of −2.1; P ≤ 0.01 and −3.1; P ≤ 0.05, respectively). A non-
significant trend for up-regulation of the fliC gene (ratios
of 25.8 and +20.8, respectively) was noted while a non-
significant trend for down-regulation of the stxB2 gene (ratios
of −4.6 and −4.2, respectively) was observed. In the case of
fermentation by B. crudilactis FR/62/B/3, a slight non-significant
trend for down-regulation of the luxS gene was observed
(ratio of−2.1).
Effect of CFSM on S. Typhimurium
Virulence Gene Expression
After incubation of 4 h, the OD measurements showed no
negative impact on growth. The average OD of S. Typhimurium
at 600 nm and after 4 h of exposure was 0.862 ± 0.078. From
every tested housekeeping gene, gmk was the most stable and
was chosen to normalize and adjust the results according to the
efficiency of each pair of primers (virulence genes hilA, ssrB2, and
sopD) monitored using qPCR (Guri et al., 2016, Table 5). The
CFSM of MRS2-3′SL medium fermented by B. bifidum induced
a slight down-regulation of the ssrB2 gene (−2.1; P ≤ 0.05). The
same trend was observed for the genes hilA and sopD (−2.5 and
−1.9, respectively). MRS2-3′SL CFSM fermented by B. crudilactis
FR/62/B/3 did not show any significant effect on virulence gene
expression (Figure 4B). A significant increase of sopD expression
is observed but too light to be biologically meaningful (1.1; P ≤
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0.05), and the same but non-significant trend is observed with
hilA gene (1.6). Interestingly, a down-regulation of virulence
genes was observed with CFSM obtained from MRS2 without
glucose. In the case of fermentation by B. crudilactis FR/62/B/3,
the genes hilA, ssrB2 and sopDwere down regulated (−8.3,−10.9,
and −6.2, respectively; P ≤ 0.05). The same but non-significant
trend was observed for B. bifidum BBA1 (−8.5, −8.0, and −2.6,
respectively, Figure 4A).
DISCUSSION
B. crudilactis FR/62/B/3 presented the best growth potential
compared to B. bifidum BBA1, particularly with whey or 3′SL
instead of glucose. This could be explained by the fact that
B. crudilactis FR/62/B/3 was originally isolated from raw cow
milk and raw milk cheese. This species possesses the genetic
machinery suggesting some ability to synthetize specific enzymes
for BMO degradation, as highlighted by the presence of genes
coding for β-galactosidase and α- or β-glucosidase, genes also
present in other bacteria such as B. bifidum, B. longum subsp.
infantis, B. mongoliense, B. biavatii, B. kashiwanohense, and B.
stellenboschense (Delcenserie et al., 2007; Milani et al., 2014,
2015; Bondue and Delcenserie, 2015). B. bifidum BBA1 grew
as well on medium containing 3′SL as the main carbohydrate
source. This species possesses genes encoding some of the
enzymes cleaving BMO bonds, so their expression would lead
to growth. However, the growth results of bifidobacteria on
this media were similar to those observed with MRS2 G
(control). This could mean that those genes may not be
expressed efficiently under the conditions tested, or another
function is necessary. A next step would be to measure the
expression of genes involved in carbohydrate metabolism such
as genes coding for β-galactosidase and α- or β-glucosidase
to validate the expression of those genes in the presence of
BMO. Another hypothesis could be attributed to the presence
of residual glucose from MRS culture allowing bifidobacteria to
grow in medium exempt of carbohydrate. Indeed, the glucose
present in initial MRS medium was in excess (Tanimomo
et al., 2016), but a negligible part of it (maximum 1mg) has
been transferred with the inoculum. Another source of glucose
could be the presence of residual carbohydrate in the yeast
extracts or peptone extracts used in MRS media. The positive
effects of media supplemented with milk products on growth
of probiotics has been demonstrated previously (Champagne
et al., 2014). This is confirmed in the present study as the best
levels of growth were reached on MRS2-Wh media for both
strains studied. In addition to BMO, whey is rich in lactose
(Food and Agriculture Organization/Organisation Mondiale de
la Santé, 1998), a carbohydrate source that is easily consumed by
bifidobacteria (Delcenserie et al., 2007).
As demonstrated previously, the CFSM obtained from some
lactic acid bacteria or bifidobacteria can induce a decrease
in virulence gene expression of pathogenic bacteria such as
C. jejuni (Mundi et al., 2013). Likewise, B. bifidum ATCC
29521, and L. acidophilus La-5 CFSM were able to produce
metabolites inhibiting virulence gene expression of E. coli
O157:H7 (Medellin-Pena et al., 2007) and S. Typhimurium
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FIGURE 3 | Effect of CFSM from MRS2 G medium (A), MRS2 medium (B), MRS2-Wh medium (C), and MRS2-3′ SL medium (D) fermented by B. bifidum
(light gray) and B. crudilactis (dark gray) on virulence gene expression of enterohaemorrhagic E. coli O157:H7 (EHEC) after 4 h of incubation. Gene
expression ratios of E. coli O157:H7 were normalized to the expression of the housekeeping gene recA and compared with those of the unfermented media. Negative
values represent down-regulation of genes and positive values represent up-regulation of genes. *P ≤ 0.05; **P ≤ 0.01.
(Bayoumi and Griffiths, 2012). In our study, CFSM collected
from MRS2-3′SL medium fermented by B. bifidum BBA1 and
B. crudilactis FR/62/B/3 down-regulated most of the virulence
genes tested in E. coli O157:H7, except the fliC gene, which
tended to be up-regulated. This is not surprising according
to the fact that fliC gene is not coded by the LEE operon
and therefore not necessarily regulated as other virulence genes
involved in T3SS and situated within the LEE operon (Falcao
et al., 2004). No significant effect has been observed with CFSM
fromMRS2 andMRS2-Whmedium. In addition, CFSMobtained
from bifidobacteria grown in media enriched in 3′SL were able
to affect virulence gene expression of E. coli O157:H7 without
having any impact on its growth, at least during the first 4 h of
incubation.
In those media, higher in carbohydrates, more fermentation
products such as lactate or acetate are synthetized and could
have an inhibiting effect on pathogenic bacteria, as well as
acidifying the media. However, all CFSM were neutralized
before testing them against E. coli or Salmonella, meaning that
the pH did not exert any effect on E. coli O157:H7 growth.
Furthermore, under neutral pH, the organic acids were under
dissociated form and should not present any bactericidal or
bacteriostatic action, contrary to un-dissociated forms (Momose
and Hirayama, 2008).
The genes involved in virulence expression such as ler but
also fliC genes are regulated by luxS, involved in quorum
sensing. However, nutrients can interfere with quorum sensing
mechanisms (Henke and Bassler, 2004; Kaper et al., 2004;
Nakanishi et al., 2006; Mellies et al., 2007) and induce a
decrease in virulence gene expression through a decrease in luxS
expression. Delcenserie et al. (2012) previously demonstrated the
effects of glucose in down-regulating virulence gene expression
of E. coli O157:H7. The present study brought out similar
observations with lactose instead of glucose (data not shown).
The ler gene was the most affected by the presence of those
carbohydrates and the effect was dose-dependent. Media used as
controls and containing glucose or lactose (MRS2 and MRS2-
Wh) down-regulated this gene but no effect was observed with
medium containing mainly 3′SL as a source of carbohydrate
(MRS2-3′SL).
To be able to metabolize 3′SL, B. bifidum and B. crudilactis
have to secrete sialidases through which NeuAc (sialic acid) can
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TABLE 5 | Effect of CFSM on expression (cycle threshold values ± standard error) of virulence gene expression of S. Typhimurium after 4 h incubation.
Gene PCR efficiencya (%) BHI controlb Test supernatants from CFSM from fermented media CFSM from fermented media
unfermented mediac by B. bifidumd by B. crudilactise
MRS2 G MRS2-3′SL MRS2 G MRS2-3′SL MRS2 G MRS2-3′SL
gmk 100 23 23.3 ± 0.3 24.4 ± 1.2 23.4 ± 0.4 24.4 ± 1.6 21.8 ± 0.2 25.0 ± 1.6
hilA 91 31.5 28.6 ± 0.2 31.2 ± 0.7 31.4 ± 2.8 32.5 ± 1.2 30.2 ± 0.4 31.3 ± 2.0
ssrB2 115 31.2 28.7 ± 1.1 30.8 ± 0.1 30.9 ± 1.6 31.6 ± 1.6 30.2 ± 0.6 32 ± 2.0
sopD 91 30.1 27.7 ± 0.5 30.2 ± 1.0 29.3 ± 1.6 31.2 ± 1.5 28.9 ± 0.6 30.9 ± 2.1
aPCR efficiency: E = [(10(-1/slope))/2] x 100%.
bS. Typhimurium grown in BHI broth for 4 h.
cS. Typhimurium grown in BHI broth supplemented with concentrated supernatants from culture media unfermented for 4 h.
dS. Typhimurium grown in BHI broth supplemented with concentrated supernatants from culture media fermented B. bifidum for 4 h.
eS. Typhimurium grown in BHI broth supplemented with concentrated supernatants from culture media fermented B. crudilactis for 4 h.
FIGURE 4 | Effect of CFSM from MRS2 G medium (A) and MRS2-3′ SL medium (B) fermented by B. bifidum (light gray) and B. crudilactis (dark gray) on
virulence gene expression of S. Typhimurium after 4 h of incubation. Gene expression ratios of S. Typhimurium were normalized to the expression of the
housekeeping gene gmk and compared with those of the unfermented media. Negative values represent down-regulation of genes and positive values represent
up-regulation of genes. *P ≤ 0.05.
be produced. B. bifidum does not use this sialic acid, which is
available for other bacteria such as B. breve (Milani et al., 2015).
Therefore, if 3′SL is metabolized by B. bifidum, free sialic acid
was probably present in fermented CFSM from 3′SL medium.
Usually, pathogenic bacteria are able to bind this free sialic acid to
their cell surface and use it to improve their resistance to the host’s
innate immune response, or can consume it as a nutrient (Vimr
et al., 2004; Severi et al., 2007). NeuAc also exerts a major role
in Salmonella enterica subsp. enterica serovar Typhi adhesion
to intestinal epithelium (Sakarya et al., 2010). This means that
in theory, sialic acid could have an impact on S. Typhimurium
and E. coli growth, but no effect on growth as measured by OD
has been observed. In addition, NeuAc had probably no impact
on virulence gene expression in our study, when supplied in the
medium.
The non-significant trend for up-regulation of fliC observed
in our study should be clarified. Indeed, this trend seems higher
when E. coli O157:H7 was exposed to CFSM from fermented
3′SL. A hypothesis could be that the presence of residual complex
carbohydrates affects gene expression of fliC. The presence or
absence of some nutrients, or stress, could play a role in virulence
expression, including fliC (Mei et al., 2015). Several studies
investigated the effects of some stress (oxidative stress, heat
shock, long storage) on down-regulation of fliC gene while other
virulence genes were upregulated (Carey et al., 2009; Mei et al.,
2015; Singh and Jiang, 2015). The experimental protocol of this
study submitted E. coli O157:H7 to some stress, which may
influence virulence gene expression. Genes involved in general
stress (uspA and rpoS), in starvation (phoA and dpS), in cold
shock (cspA, cspC, and cspE) and in acid resistance (gadW)
have been investigated and the results have shown that the
different treatments did not affect expression of stress-related
genes (data not shown). This leads us to suppose that virulence
factor expression has not been influenced by the experimental
conditions.
The results observed using RT-qPCR with CFSM from
fermented MRS2-3′SL on S. Typhimurium virulence gene
expression did not confirm the results observed with luminescent
reporter strains. However, CFSM obtained after fermentation
of MRS2 without any glucose fermented by B. crudilactis
FR/62/B/3 down-regulated several virulence genes. Regarding
B. bifidum BBA1 CFSM, a trend to down-regulation was
observed as well. These down-regulations could be caused by
other non-carbohydrate metabolites produced by bifidobacteria
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and these bioactive molecules could originate from the
degradation of proteins. Most known bioactive molecules, such
as subpeptin JM4-A and subpeptin JM4-B are antimicrobial
peptides synthetized by Bacillus subtilis and active against
Salmonella, Staphylococcus aureus, and Bacillus cereus (Sumi
et al., 2015). Nisin, a bacteriocin well known, is produced by
Lactococcus lactis and has a negative impact on Listeria or
Clostridium (Ebbensgaard et al., 2015). The results of our study
suggest that the CFSM activity is not due to an antimicrobial
effect but due to an antivirulent effect.
In conclusion, this study provides the information that
CFSM obtained from MRS2-3′SL medium fermented by B.
bifidum BBA1 and B. crudilactis FR/62/B/3 down-regulated
LEE1 expression of the luminescent E. coli reporter strain
and hilA expression of luminescent S. Typhimurium reporter
strain. These results agree with the decreasing virulence gene
expression of ler and qseA for E. coli, but not for S.
Typhimurium. The contact between S. Typhimurium and CFSM
from fermented MRS without glucose showed down-regulation
of genes hilA, ssrB2, and sopD. According to this in vitro
study, the antivirulent metabolites issuing from fermentation by
bifidobacteria could have a negative impact on T3SS of both
pathogens, decreasing expression of genes mainly implicated
in this virulence mechanism (ler and qseA genes for E. coli
O157:H7; hilA, ssrB2, and sopD genes for S. Typhimurium). The
potential upregulation of fliC in E. coli O157:H7 could increase
the motility as well as biofilm formation. A phenotypic analysis
of the pathogens under the experimental conditions could bring
more insights about its virulence pattern. Information is lacking
about the nature of the active molecules, but the activity of
those CFSM might be due to small peptides or proteins with low
molecular weight and resistant to pH modification and heat, or
products obtained from carbohydrate metabolism. Size exclusion
chromatography could contribute to separating and isolating
these bioactive molecules in order to identify them. In the future,
the effects of these metabolites will be investigated in a human
gastrointestinal model to study the impact on microbiota to
mimic in vivo conditions.
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